No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
William Blair Initiates Elevation Oncology(ELEV.US) With Buy Rating
Analysts' Top Healthcare Picks: Opus Genetics (IRD), Elevation Oncology (ELEV)
H.C. Wainwright Maintains Elevation Oncology(ELEV.US) With Buy Rating, Maintains Target Price $6
Promising Pipeline and Strategic Advances Support Buy Rating for Elevation Oncology